RSSIn Focus

Topical Ivermectin: Data Supporting Dual Modes of Action in Rosacea

Topical Ivermectin: Data Supporting Dual Modes of Action in Rosacea

| September 1, 2017

by James Q. Del Rosso, DO, FAOCD, FAAD Dr. Del Rosso is Research Director at JDR Dermatology Research in Las Vegas, Nevada; Adjunct Clinical Professor of Dermatology at Touro University Nevada, Las Vegas; and with Dermatology and Cutaneous Surgery at Thomas Dermatology in Las Vegas, Nevada. Funding: The author did not receive any form of […]

Continue Reading

Topical Alpha-Agonist Therapy for Persistent Facial Erythema of Rosacea and the Addition of Oxmetazoline to the Treatment Armamentarium: Where Are We Now?

Topical Alpha-Agonist Therapy for Persistent Facial Erythema of Rosacea and the Addition of Oxmetazoline to the Treatment Armamentarium: Where Are We Now?

| July 1, 2017

by James Q. Del Rosso, DO, FAOCD, FAAD Dr. Del Rosso is Research Director at JDR Dermatology Research, Las Vegas, Nevada and at Henderson Dermatology Research in Henderson, Nevada; is Adjunct Clinical Professor (Dermatology) at ableouro University Nevada, Las Vegas, Nevada; and practices Dermatology and Cutaneous Surgery at Thomas Dermatology in Las Vegas, Nevada. J […]

Continue Reading

A Closer Look at Seborrheic Keratoses: Patient Perspectives, Clinical Relevance, Medical Necessity, and Implications for Management

A Closer Look at Seborrheic Keratoses: Patient Perspectives, Clinical Relevance, Medical Necessity, and Implications for Management

| March 1, 2017

James Q. Del Rosso, DO, FAOCD, FAAD Research Director, JDR Dermatology Research and Private Dermatology Practice, Thomas Dermatology, Las Vegas, Nevada Disclosure: Dr. Del Rosso serves as a consultant to Aclaris Therapeutics, Inc. (Malvern, Pennsylvania) that  has a topical therapy for seborrheic keratosis under development. He also served as a consultant for and as the […]

Continue Reading

Emerging Issues in Adult Female Acne

Emerging Issues in Adult Female Acne

| January 1, 2017

aJoshua A. Zeichner, MD; bHillary E. Baldwin, MD; cFran E. Cook-Bolden, MD; dLawrence F. Eichenfield, MD; dSheila Fallon-Friedlander, MD; eDavid A. Rodriguez, MD aMount Sinai Hospital, New York, New York bMorristown, New Jersey cSkin Specialty Dermatology, New York, New York dUniversity of California, Rady Children’s Hospital, San Diego, California eDermatology Associates/Research, Coral Gables, Florida; cRedwood […]

Continue Reading

Oral Apremilast for the Treatment  of Plaque Psoriasis

Oral Apremilast for the Treatment of Plaque Psoriasis

| September 1, 2016

James Q. Del Rosso, DO; Leon Kircik, MD Disclosures (related to this manuscript): Dr. Del Rosso is a speaker, consultant, and/or researcher for Anacor, Aqua, Allergan, Bayer, Celgene, Galderma, LeoPharma, Novartis, Pharmaderm, Promius, SunPharma, and Valeant. Dr. Kircik is either a speaker, consultant, or investigator for Amgen, Anacor, Aqua, Allergan, Bayer, Celgene, Coherus, Eli Lilly, […]

Continue Reading

Application of Nail Polish During Topical Management of Onychomycosis Are Data Available to Guide the Clinician  About What to Tell Their Patients?

Application of Nail Polish During Topical Management of Onychomycosis Are Data Available to Guide the Clinician About What to Tell Their Patients?

| August 1, 2016

James Q. Del Rosso, DO, FAOCD, FAAD Adjunct Clinical Professor (Dermatology), Touro University Nevada, Henderson, Nevada; Research Director, Del Rosso Dermatology Research, Las Vegas, Nevada; Private Practice, Lakes Dermatology, Las Vegas, Nevada Disclosure: Dr. Del Rosso served as the sole author of this manuscript. No individual or group from any company or agency participated in […]

Continue Reading